Aurobindo Pharma Ltd

AUROBINDO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform that a Meeting of the Board of Directors of the Company will be held on Thursday February 9 2023 to consider and approve inter alia the following:1. Standalone & Consolidated Unaudited Financial Results of the Company for the third quarter and nine months period ended December 31 2022 and2. Payment of Interim Dividend if any for the financial year 2022-23.Further to our letter dated December 29 2022 informing about the closure of Trading Window of the Company from January 1 2023 until 48 hours from the date of declaration of the Unaudited Financial Results of the Company for the third quarter and nine months period ended December 31 2022 we inform you that the Trading Window will remain closed up to February 11 2023 and shall be re-opened on February 12 2023.